INV-9956

· Shenzhen Ionova Life Sciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INV-9956, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing